Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Deniz Guven Karakurt, Ugur Demirsoy, Funda Corapcioglu, Selim Oncel, Meriban Karadogan & Emin Sami Arisoy. (2014) Do Proinflammatory Cytokine Levels Predict Serious Complication Risk of Infection in Pediatric Cancer Patients?. Pediatric Hematology and Oncology 31:5, pages 415-424.
Read now
Read now
Metin Demirkaya, Solmaz Çelebi, Betül Sevinir & Mustafa Hacımustafaoglu. (2013) Randomized Comparison of Piperacillin–Tazobactam Plus Amikacin Versus Cefoperazone-Sulbactam Plus Amikacin for Management of Febrile Neutropenia in Children with Lymphoma and Solid Tumors. Pediatric Hematology and Oncology 30:2, pages 141-148.
Read now
Read now
Emine Zengin, Nazan Sarper & Suar Çakı Kılıç. (2011) Piperacillin/Tazobactam Monotherapy Versus Piperacillin/Tazobactam Plus Amikacin as Initial Empirical Therapy for Febrile Neutropenia in Children with Acute Leukemia. Pediatric Hematology and Oncology 28:4, pages 311-320.
Read now
Read now
Hacı Ahmet Demir, Tezer Kutluk, Mehmet Ceyhan, Begül Yağcı-Küpeli, Canan Akyüz, Bülent Cengiz, Ali Varan, Ateş Kara, Bilgehan Yalçın, Gülten Seçmeer & Münevver Büyükpamukçu. (2011) Comparison of Sulbactam-Cefoperazone with Carbapenems as Empirical Monotherapy for Febrile Neutropenic Children with Lymphoma and Solid Tumors. Pediatric Hematology and Oncology 28:4, pages 299-310.
Read now
Read now
Maria F Wolf & Arne Simon. (2009) The use of piperacillin–tazobactam in neonatal and paediatric patients. Expert Opinion on Drug Metabolism & Toxicology 5:1, pages 57-69.
Read now
Read now
Lorenzo Drago & Elena De Vecchi. (2008) The safety of cefepime in the treatment of infection. Expert Opinion on Drug Safety 7:4, pages 377-387.
Read now
Read now
I. Yildirim, S. Aytac, M. Ceyhan, M. Cetin, M. Tuncer, A. B. Cengiz, G. Secmeer & S. Yetgin. (2008) PIPERACILLIN/TAZOBACTAM PLUS AMIKACIN VERSUS CARBAPENEM MONOTHERAPY AS EMPIRICAL TREATMENT OF FEBRILE NEUTROPENIA IN CHILDHOOD HEMATOLOGICAL MALIGNANCIES. Pediatric Hematology and Oncology 25:4, pages 291-299.
Read now
Read now
Niklas Stabell, Ellen Nordal, Einar Stensvold, Karianne Wiger Gammelsrud, Bendik Lund, Arne Taxt, Frauke Buhring, Margrethe Greve-Isdahl, Hans Petter Fornebo, Gunnar Skov Simonsen & Claus Klingenberg. (2008) Febrile neutropenia in children with cancer: A retrospective Norwegian multicentre study of clinical and microbiological outcome. Scandinavian Journal of Infectious Diseases 40:4, pages 301-307.
Read now
Read now
Articles from other publishers (38)
Najmul Karim, Alamgir Kabir, Manirul Islam, Akhil Ranjan Biswas, Mohammed Wasim, Mahbubul Alam, Nobendu Chowdhury, Mohammed Nadimul Islam, Tamanna Tabassum & Mohammad Jahid Hasan. (2022) Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience. The Egyptian Journal of Internal Medicine 34:1.
Crossref
Crossref
Rachel L Wattier & Adam J Esbenshade. (2022) From “More is Better” to “Less is More”: A Commentary on Antimicrobial Use in Pediatric Oncology. Journal of the Pediatric Infectious Diseases Society 11:5, pages 229-238.
Crossref
Crossref
Halil Gökce, Fatih Şen, Yusuf Sert, Bakr F. Abdel-Wahab, Benson M. Kariuki & Gamal A. El-Hiti. (2022) Quantum Computational Investigation of (E)-1-(4-methoxyphenyl)-5-methyl-N′-(3-phenoxybenzylidene)-1H-1,2,3-triazole-4-carbohydrazide. Molecules 27:7, pages 2193.
Crossref
Crossref
Xinmei Tan, Yan Li, Jiaxi Xi, Sitong Guo, Henghai Su, Xiaoyu Chen & Xueyan Liang. (2021) Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia. Medicine 100:50, pages e27266.
Crossref
Crossref
Na Hee Lee, Ji-Man Kang, Ji Won Lee, Hee Jae Huh, Nam Yong Lee, Keon Hee Yoo, Ki Woong Sung, Hong Hoe Koo & Yae-Jean Kim. (2020) Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance. Pediatric Infectious Disease Journal 39:10, pages 931-936.
Crossref
Crossref
Shoji Saito, Ryu Yanagisawa, Kisei Minami, Eriko Uchida, Tatsuo Watanabe, Kazutoshi Komori, Takashi Kurata, Tomohiko Nakamura & Kazuo Sakashita. (2020) Prophylactic piperacillin administration in pediatric patients with solid tumors following different intensities of chemotherapy. Pediatrics International 62:2, pages 158-168.
Crossref
Crossref
Saber Jan, Braveen Ragunanthan, Sandra R. DiBrito, Omolabake Alabi & Maria Gutierrez. (2018) Cefepime Efficacy and Safety in Children: A Systematic Review and Meta-analysis. Frontiers in Pediatrics 6.
Crossref
Crossref
Nikolaos Andreatos, Myrto Eleni Flokas, Anna Apostolopoulou, Michail Alevizakos & Eleftherios Mylonakis. (2017) The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis. Open Forum Infectious Diseases 4:3.
Crossref
Crossref
Thomas LehrnbecherPaula RobinsonBrian FisherSarah AlexanderRoland A. AmmannMelissa BeaucheminFabianne CarlesseAndreas H. GrollGabrielle M. HaeuslerMaria SantolayaWilliam J. SteinbachElio CastagnolaBonnie L. DavisL. Lee DupuisAditya H. GaurWim J.E. TissingTheo ZaoutisRobert PhillipsLillian Sung. (2017) Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. Journal of Clinical Oncology 35:18, pages 2082-2094.
Crossref
Crossref
Hirozumi Sano, Ryoji Kobayashi, Daisuke Suzuki, Daiki Hori, Kenji Kishimoto & Kunihiko Kobayashi. (2017) A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders. Pediatric Blood & Cancer 64:6, pages e26360.
Crossref
Crossref
Mohammad Aamir, Pankaj Abrol, Deepak Sharma & Harish Punia. (2015) A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India. Tropical Doctor 46:3, pages 142-148.
Crossref
Crossref
Konstantinos Z. Vardakas, Kyriakos K. Trigkidis, Eleni Boukouvala & Matthew E. Falagas. (2016) Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. International Journal of Antimicrobial Agents 48:1, pages 1-10.
Crossref
Crossref
Paula D. RobinsonThomas LehrnbecherRobert PhillipsL. Lee DupuisLillian Sung. (2016) Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials. Journal of Clinical Oncology 34:17, pages 2054-2060.
Crossref
Crossref
Helen L. Leather & John R. Wingard. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
1038
1062
.
Kazuo Tamura, Nobu Akiyama, Yoshinobu Kanda & Masahiro Saito. (2015) Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan. Journal of Infection and Chemotherapy 21:9, pages 654-662.
Crossref
Crossref
Hirozumi Sano, Ryoji Kobayashi, Daisuke Suzuki, Kenji Kishimoto, Kazue Yasuda & Kunihiko Kobayashi. (2015) Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study. Pediatric Blood & Cancer 62:2, pages 356-358.
Crossref
Crossref
Takeo Sarashina, Ryoji Kobayashi, Makoto Yoshida, Naohisa Toriumi, Daisuke Suzuki, Hirozumi Sano & Hiroshi Azuma. (2014) A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients. Pediatric Blood & Cancer 61:11, pages 1992-1995.
Crossref
Crossref
Gulay Sezgin, Can Acipayam, Ayse Ozkan, Ibrahim Bayram & Atila Tanyeli. (2014) Meropenem Versus Piperacillin-Tazobactam as Empiric Therapy for Febrile Neutropenia in Pediatric Oncology Patients. Asian Pacific Journal of Cancer Prevention 15:11, pages 4549-4553.
Crossref
Crossref
Heidi V. Russell, Janki Panchal, Helena VonVille, Luisa Franzini & J. Michael Swint. (2013) Economic Evaluation of Pediatric Cancer Treatment: A Systematic Literature Review. Pediatrics 131:1, pages e273-e287.
Crossref
Crossref
Arif Manji, Thomas Lehrnbecher, L. Lee Dupuis, Joseph Beyene & Lillian Sung. (2011) A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia. Supportive Care in Cancer 20:10, pages 2295-2304.
Crossref
Crossref
Arif Manji, Thomas Lehrnbecher, L. Lee Dupuis, Joseph Beyene & Lillian Sung. (2012) A Meta-analysis of Antipseudomonal Penicillins and Cephalosporins in Pediatric Patients With Fever and Neutropenia. Pediatric Infectious Disease Journal 31:4, pages 353-359.
Crossref
Crossref
Serap Karaman, Sema Vural, Yildiz Yildirmak, Merve Emecen, Ela Erdem & Rejin Kebudi. (2011) Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia. Pediatric Blood & Cancer 58:4, pages 579-583.
Crossref
Crossref
Mizuho Ichikawa, Daisuke Suzuki, Junjiro Ohshima, Yuko Cho, Makoto Kaneda, Akihiro Iguchi & Tadashi Ariga. (2011) Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia. Pediatric Blood & Cancer 57:7, pages 1159-1162.
Crossref
Crossref
Mical Paul, Dafna Yahav, Assaf Bivas, Abigail Fraser & Leonard Leibovici. (2011) Cochrane Review: Anti‐pseudomonal beta‐lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta‐lactams. Evidence-Based Child Health: A Cochrane Review Journal 6:6, pages 2026-2185.
Crossref
Crossref
Debra L. Palazzi. (2011) The Use of Antimicrobial Agents in Children With Fever During Chemotherapy-induced Neutropenia. Pediatric Infectious Disease Journal 30:10, pages 887-890.
Crossref
Crossref
Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz, Michael J. Boeckh, James I. Ito, Craig A. Mullen, Issam I. Raad, Kenneth V. Rolston, Jo-Anne H. Young & John R. Wingard. (2011) Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 52:4, pages e56-e93.
Crossref
Crossref
Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz, Michael J. Boeckh, James I. Ito, Craig A. Mullen, Issam I. Raad, Kenneth V. Rolston, Jo-Anne H. Young & John R. Wingard. (2011) Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases 52:4, pages 427-431.
Crossref
Crossref
Mical Paul, Dafna Yahav, Assaf Bivas, Abigail Fraser & Leonard Leibovici. (2010) Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database of Systematic Reviews 2015:2.
Crossref
Crossref
Elisabeth E. Adderson, Patricia M. Flynn & James M. Hoffman. (2010) Efficacy and Safety of Cefepime in Pediatric Patients: A Systematic Review and Meta-Analysis. The Journal of Pediatrics 157:3, pages 490-495.e1.
Crossref
Crossref
Mark Weinblatt. 2011. Clinical Manual of Emergency Pediatrics. Clinical Manual of Emergency Pediatrics
332
361
.
Sema Vural, Ela Erdem, Seda Geylani Gulec, Yildiz Yildirmak & Rejin Kebudi. (2010) Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia. Pediatrics International 52:2, pages 262-267.
Crossref
Crossref
Susana Chavez-Bueno & Terrence L. Stull. (2009) Antibacterial Agents in Pediatrics. Infectious Disease Clinics of North America 23:4, pages 865-880.
Crossref
Crossref
Vedat Uygun, Gulsun Tezcan Karasu, Dilara Ogunc, Akif Yesilipek & Volkan Hazar. (2009) Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: A randomized and open‐label study. Pediatric Blood & Cancer 53:4, pages 610-614.
Crossref
Crossref
L. Charles Bailey, Anne F. Reilly & Susan R. Rheingold. (2009) Infections in Pediatric Patients With Hematologic Malignancies. Seminars in Hematology 46:3, pages 313-324.
Crossref
Crossref
Ryoji Kobayashi, Tomonobu Sato, Masahide Nakajima, Makoto Kaneda & Akihiro Iguchi. (2009) Piperacillin/Tazobactam Plus Ceftazidime Versus Sulbactam/Ampicillin Plus Aztreonam as Empirical Therapy for Fever in Severely Neutropenic Pediatric Patients. Journal of Pediatric Hematology/Oncology 31:4, pages 270-273.
Crossref
Crossref
Stéphane Paulus & Simon Dobson. 2009. Hot Topics in Infection and Immunity in Children V. Hot Topics in Infection and Immunity in Children V
185
204
.
Abhijit M. Bal & Ian M. Gould. (2007) Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia. International Journal of Antimicrobial Agents 29:5, pages 501-509.
Crossref
Crossref
David J. Weber. (2006) Collateral damage and what the future might hold. The need to balance prudent antibiotic utilization and stewardship with effective patient management. International Journal of Infectious Diseases 10, pages S17-S24.
Crossref
Crossref